Synchronous carcinoma breast with chronic myelogenous leukemia: A rare presentation.

Bahl, A; Dhiman, A; Talwar, V; Doval, D C

Bahl, A; Dhiman, A; Talwar, V; Doval, D C.

Indian J Cancer ; 2010 Oct-Dec; 47(4): 477-479

Article in English | IMSEAR | ID: sea-144397

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/pathology; Breast Neoplasms/therapy; Carcinoma, Ductal, Breast/pathology; Carcinoma, Ductal, Breast/therapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Female; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy; Mastectomy; Middle Aged; Neoplasms, Multiple Primary/pathology; Neoplasms, Multiple Primary/therapy; Piperazines/administration & dosage; Pyrimidines/administration & dosage; Radiotherapy; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators/administration & dosage; Tamoxifen/administration & dosage; Taxoids/administration & dosage

Fulltext

XML

Search on Google

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Piperazines / Pyrimidines / Radiotherapy / Tamoxifen / Breast Neoplasms / Female / Humans / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin Language: English Journal: Indian J Cancer Year: 2010 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google